Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Dr. Reddy's Laboratories, Inc.

Dr. Reddy's Laboratories, Inc. Recalls

All product recalls associated with Dr. Reddy's Laboratories, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

167

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 141–160 of 167 recalls

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

1...6 789

Page 8 of 9Next

FDA

Aug 13, 2015

Nationwide

• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine-Atorvastatin Tablets (Dr. Reddy's) – Subpotent Drug (2015)

Subpotent Drug: Subpotent atorvastatin.

Class IIILow

FDAAug 13, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Rivastigmine Tartrate Capsules (Dr. Reddy's) – Dissolution Failure (2015)

Failed Dissolution Specifications

Class IIModerate

FDAAug 3, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Divalproex Sodium Tablets (Dr. Reddy's) – dissolution failure (2015)

Failed Dissolution Specifications; exceeded specification at the 9 hour time point

Class IIModerate

FDAMay 22, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Divalproex Sodium Tablets (Dr. Reddy's) – Dissolution Specs Exceeded (2015)

Failed Dissolution Specifications; exceeded specification at the 9 hour time point

Class IIModerate

FDAMay 22, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine Atorvastatin 10/10mg (Dr. Reddy's) – Subpotent Medication (2015)

Subpotent drug

Class IIILow

FDAMay 6, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine Atorvastatin 5/10mg (Dr. Reddy's) – Subpotent Medication (2015)

Subpotent drug

Class IIILow

FDAMay 6, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine Atorvastatin 5/40mg (Dr. Reddy's) – Subpotent Medication (2015)

Subpotent drug

Class IIILow

FDAMay 6, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Amlodipine Atorvastatin 10/40mg (Dr. Reddy's) – Subpotent Medication (2015)

Subpotent drug

Class IIILow

FDAMay 6, 2015Nationwide• Dr. Reddy's Laboratories, Inc.

Metoprolol Succinate Tablets (Dr. Reddy's) – failed dissolution (2014)

Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point.

Class IIModerate

FDAMay 23, 2014Nationwide• Dr. Reddy's Laboratories, Inc.

Lansoprazole Capsules (Dr. Reddy's) – Microbial Contamination (2014)

Microbial Contamination of Non-Sterile Products: Out-of-specification results for microbial count were observed at the initial stability interval for Lansoprazole Delayed Release Capsules.

Class IIModerate

FDAJan 3, 2014Nationwide• Dr. Reddy's Laboratories, Inc.

Metoprolol Succinate Tablets (Dr. Reddy's) – Dissolution Issue (2013)

Failed Dissolution Specification; 12-Month stability interval.

Class IIModerate

FDADec 13, 2013LA, MI, MS +2 more• Dr. Reddy's Laboratories, Inc.

Ibuprofen Tablets (Dr. Reddy's) – Incorrect Expiration (2013)

Labeling: Incorrect or missing lot and/or exp date- This product is being recalled due to an incorrect expiration date of 05/2017. The correct expiration date is 10/2016.

Class IIModerate

FDAAug 29, 2013Nationwide• Dr. Reddy's Laboratories, Inc.

Ranitidine Tablets (Dr. Reddy's) – Microbial Contamination (2013)

Microbial Contamination of Non-Sterile Products: A lot of raw material used in the manufacture of Ranitidine was positive for Pseudomonas sp.

Class IIModerate

FDAAug 2, 2013Nationwide• Dr. Reddy's Laboratories, Inc.

Tizanidine Tablets (Dr. Reddy's) – Labeling Issue (2013)

Labeling Illegible: There is a possibility that the bottle labels do not contain the strength of the product as well as other printing details.

Class IIILow

FDAMar 19, 2013Nationwide• Dr. Reddy'S Laboratories